Skip to main content

Table 1 Clinicopathologic characteristics of patients according to age

From: Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China

Age

<40y

40 ~ 50y

P value

character

No.

%

No.

%

T stage

    

<0.01

T1

520

38.2

1072

34.5

 

T2

625

46.0

1914

56.3

 

T3

215

15.8

124

9.2

 

N stage

    

0.07

N0

626

46.0

1580

50.8

 

N1

324

23.8

787

25.3

 

N2

324

23.8

606

19.5

 

N3

86

6.4

137

4.4

 

Family history

    

<0.01

Yes

80

5.9

44

1.4

 

No

1280

94.1

3066

98.6

 

Tumor Grade

    

<0.01

Grade I

56

4.1

93

3.0

 

Grade II

775

57

2233

71.8

 

Grade III

529

38.9

784

25.2

 

Tumor type

    

0.4

IDC

1216

89.4

2762

88.8

 

ILC

60

4.4

168

5.4

 

Others

84

6.2

180

5.8

 

LVI

    

<0.01

Positive

413

30.4

790

25.4

 

Negative

947

69.6

2320

74.6

 

ER status

    

<0.01

Positive

821

60.4

2133

68.6

 

Negative

539

39.6

977

31.4

 

PR status

    

0.9

Positive

826

60.7

1894

60.9

 

Negative

534

39.3

1216

39.1

 

HER2 status

    

0.01

Positive

390

28.7

647

20.8

 

Negative

970

71.3

2463

79.2

 

Subtype

    

<0.01

Luminal A

660

48.5

1959

59.2

 

Luminal B

344

25.3

579

17.5

 

Her2 positive

129

9.5

327

9.9

 

Triple negative

227

16.7

445

13.4

 

Srugery

    

<0.01

BCS

223

16.4

236

7.6

 

Mastectomy

1137

83.6

2874

92.4

 

Endocrine therapy

    

0.7

No

204

15.0

442

14.2

 

Yes

1156

85

2668

85.8

 

Chemotherapy

    

0.4

No

92

6.8

308

9.9

 

Yes

1268

93.2

2802

90.1

 

Radiotherapy

    

0.1

No

1020

75.0

2568

82.6

 

Yes

340

25.0

542

17.4

 
  1. Abbreviation:
  2. IDC intraductal carcinoma.
  3. ILC intralobular carcinoma.
  4. LVI  lymphovascular invasion.
  5. ER eostregen receptor.
  6. PR progesterone receptor.
  7. BCS breast conservative surgery.